Literature DB >> 15549472

Long-term pain relief effects in four patients undergoing percutaneous vertebroplasty for metastatic vertebral tumor.

Keisuke Yamada1, Yoshihisa Matsumoto, Masaki Kita, Ken Yamamoto, Takeshi Kobayashi, Tsuyoshi Takanaka.   

Abstract

We reviewed long-term pain relief in four patients undergoing percutaneous vertebroplasty (PVP) for lumbar or back pain due to metastatic vertebral tumors. The patients received anesthesiological palliative care with analgesics until their death after PVP. Pain intensity, the presence or absence of recurrence of pain, changes in dosage of analgesics given before and after PVP, and complications associated with PVP were evaluated. A numerical rating scale (NRS) from 0 (no pain) to 10 (worst pain imaginable) was used to measure pain. The patients were three men and one woman (mean age, 58 years). PVP was performed in five vertebrae (one thoracic and four lumbar). The NRS scores on moving before PVP were 10, 8, 10, and 10. After PVP, NRS decreased to 0, 3, 5, and 0, respectively, within 72 h. No recurrence of pain in the treated area occurred until death in any of these patients. The dosages of analgesics given were decreased in two cases, but no changes were made in the other two cases. There were no complications associated with PVP. Percutaneous vertebro-plasty is a safe and effective treatment for long-time pain relief in patients with metastatic vertebral tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15549472     DOI: 10.1007/s00540-004-0252-6

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  6 in total

1.  Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine.

Authors:  Giovanni Carlo Anselmetti
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

2.  Percutaneous bone tumor management.

Authors:  Afshin Gangi; Xavier Buy
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

3.  Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients.

Authors:  Wan Soo Lee; Kyeong Hoon Sung; Hyun Tae Jeong; Youn Sang Sung; Yong In Hyun; Jae Young Choi; Kyu Seok Lee; Chul Su Ok; Young Woo Choi
Journal:  Eur Spine J       Date:  2006-07-21       Impact factor: 3.134

Review 4.  Quality improvement guidelines for bone tumour management.

Authors:  A Gangi; G Tsoumakidou; X Buy; E Quoix
Journal:  Cardiovasc Intervent Radiol       Date:  2010-02-12       Impact factor: 2.740

5.  Clinical outcome of percutaneous osteoplasty for pain caused by metastatic bone tumors in the pelvis and femur.

Authors:  Keisuke Yamada; Yoshihisa Matsumoto; Masaki Kita; Ken Yamamoto; Wataru Kohda; Takeshi Kobayashi; Tsuyoshi Takanaka
Journal:  J Anesth       Date:  2007-05-30       Impact factor: 2.078

Review 6.  Bone cement as a local chemotherapeutic drug delivery carrier in orthopedic oncology: A review.

Authors:  Sunjeev S Phull; Alireza Rahimnejad Yazdi; Michelle Ghert; Mark R Towler
Journal:  J Bone Oncol       Date:  2020-12-16       Impact factor: 4.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.